# Evaluation of Pharmacokinetic / Pharmacodynamic Data and Interest Individualized Therapeutic Drug Monitoring Glycopeptides and β-lactam-aminoglycoside ICU

> **NCT02846298** · — · UNKNOWN · sponsor: **Fondation Hôpital Saint-Joseph** · enrollment: 172 (actual)

## Conditions studied

- Severe Infection

## Interventions

- **BIOLOGICAL:** Drug Monitoring

## Key facts

- **NCT ID:** NCT02846298
- **Lead sponsor:** Fondation Hôpital Saint-Joseph
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11-08
- **Primary completion:** 2018-10-22
- **Final completion:** 2023-12-31
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2023-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02846298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02846298, "Evaluation of Pharmacokinetic / Pharmacodynamic Data and Interest Individualized Therapeutic Drug Monitoring Glycopeptides and β-lactam-aminoglycoside ICU". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02846298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*